1Combivent Inhalation Aerosol Study Group. In chronic pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone, an 85-day multicenter trial. Chest,1994,105(5):1411-1419.
2Van Schayok CP, Dompeling E, van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis:continuous or on demand:a randomized controlled study. Br Med J,1991, 303:1426-1431.
3Ingram RH Jr, Wellman JJ, Machmahin J, et al. Relative contributions to large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol.J Clin Invest,1977, 59:696-703.
5Houtmeyers E, Gosselink R, Gayan RG, et al. Effects of drugs on mucus clearance. Eur Respir J, 1999,14:452-467.
6Rennards M. Alternative mechanisms for long-acting beta(2)-adrenergic agonist in COPD.Chest,2001,120(1):258-270.
7Sichletidis L, Kottakis J, Maroou S, et al.Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.Int J Clin Pract, 1999,53(3):185-188.
